WHO Leads Global Call to Include Pregnant, Lactating Women in TB Research
The World Health Organization (WHO) has released a powerful Call to Action and Consensus Statement urging an end to the routine exclusion of pregnant and lactating women from tuberculosis (TB) research. Published as part of a global consensus initiative, the documents—developed by over 80 international experts—outline a strategic framework aimed at ensuring equitable access to TB innovations for all, particularly those most vulnerable.
Each year, approximately 200,000 pregnant or postpartum women develop TB globally. Despite this high burden, they have been largely excluded from research trials involving new TB drugs and vaccines. This exclusion creates critical evidence gaps that delay access to life-saving interventions for these populations.
“The benefits of TB research must flow to all people with TB, including pregnant and lactating women,” said Dr Tereza Kasaeva, Director of the WHO Department for HIV, TB, Hepatitis and Sexually Transmitted Infections. “It is time to prioritize their inclusion – not as an afterthought, but as a fundamental step toward equitable, evidence-based care.”
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.